Practical solutions for hypertensive patients with dyslipidemia
Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovasc...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Vlachopoulos, Charalambos [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: How do metals escape from magmas to form porphyry-type ore deposits? - Vigneresse, Jean-Louis ELSEVIER, 2018, official journal of the Association for Research into Arterial Structure and Physiology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:18 ; year:2017 ; pages:49-54 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.artres.2017.03.002 |
|---|
| Katalog-ID: |
ELV020247451 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV020247451 | ||
| 003 | DE-627 | ||
| 005 | 20230625131502.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.artres.2017.03.002 |2 doi | |
| 028 | 5 | 2 | |a GBVA2017010000010.pica |
| 035 | |a (DE-627)ELV020247451 | ||
| 035 | |a (ELSEVIER)S1872-9312(16)30097-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 550 |q VZ |
| 084 | |a 38.52 |2 bkl | ||
| 084 | |a 57.20 |2 bkl | ||
| 100 | 1 | |a Vlachopoulos, Charalambos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Practical solutions for hypertensive patients with dyslipidemia |
| 264 | 1 | |c 2017transfer abstract | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. | ||
| 520 | |a Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. | ||
| 650 | 7 | |a Hypertension |2 Elsevier | |
| 650 | 7 | |a Aortic stiffness |2 Elsevier | |
| 650 | 7 | |a Dyslipidemia |2 Elsevier | |
| 650 | 7 | |a Amlodipine |2 Elsevier | |
| 650 | 7 | |a Central pressures |2 Elsevier | |
| 650 | 7 | |a ACE inhibitors |2 Elsevier | |
| 700 | 1 | |a Ioakeimidis, Nikolaos |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Vigneresse, Jean-Louis ELSEVIER |t How do metals escape from magmas to form porphyry-type ore deposits? |d 2018 |d official journal of the Association for Research into Arterial Structure and Physiology |g Amsterdam [u.a.] |w (DE-627)ELV001651668 |
| 773 | 1 | 8 | |g volume:18 |g year:2017 |g pages:49-54 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.artres.2017.03.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-GGO | ||
| 912 | |a SSG-OPC-GEO | ||
| 936 | b | k | |a 38.52 |j Geologie der Erze |q VZ |
| 936 | b | k | |a 57.20 |j Exploration und Prospektion von Bodenschätzen |q VZ |
| 951 | |a AR | ||
| 952 | |d 18 |j 2017 |h 49-54 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
c v cv |
|---|---|
| matchkey_str |
vlachopouloscharalambosioakeimidisnikola:2017----:rciasltosohpresvptetw |
| hierarchy_sort_str |
2017transfer abstract |
| bklnumber |
38.52 57.20 |
| publishDate |
2017 |
| allfields |
10.1016/j.artres.2017.03.002 doi GBVA2017010000010.pica (DE-627)ELV020247451 (ELSEVIER)S1872-9312(16)30097-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl Vlachopoulos, Charalambos verfasserin aut Practical solutions for hypertensive patients with dyslipidemia 2017transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Elsevier Ioakeimidis, Nikolaos oth Enthalten in Elsevier Vigneresse, Jean-Louis ELSEVIER How do metals escape from magmas to form porphyry-type ore deposits? 2018 official journal of the Association for Research into Arterial Structure and Physiology Amsterdam [u.a.] (DE-627)ELV001651668 volume:18 year:2017 pages:49-54 extent:6 https://doi.org/10.1016/j.artres.2017.03.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.52 Geologie der Erze VZ 57.20 Exploration und Prospektion von Bodenschätzen VZ AR 18 2017 49-54 6 045F 610 |
| spelling |
10.1016/j.artres.2017.03.002 doi GBVA2017010000010.pica (DE-627)ELV020247451 (ELSEVIER)S1872-9312(16)30097-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl Vlachopoulos, Charalambos verfasserin aut Practical solutions for hypertensive patients with dyslipidemia 2017transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Elsevier Ioakeimidis, Nikolaos oth Enthalten in Elsevier Vigneresse, Jean-Louis ELSEVIER How do metals escape from magmas to form porphyry-type ore deposits? 2018 official journal of the Association for Research into Arterial Structure and Physiology Amsterdam [u.a.] (DE-627)ELV001651668 volume:18 year:2017 pages:49-54 extent:6 https://doi.org/10.1016/j.artres.2017.03.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.52 Geologie der Erze VZ 57.20 Exploration und Prospektion von Bodenschätzen VZ AR 18 2017 49-54 6 045F 610 |
| allfields_unstemmed |
10.1016/j.artres.2017.03.002 doi GBVA2017010000010.pica (DE-627)ELV020247451 (ELSEVIER)S1872-9312(16)30097-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl Vlachopoulos, Charalambos verfasserin aut Practical solutions for hypertensive patients with dyslipidemia 2017transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Elsevier Ioakeimidis, Nikolaos oth Enthalten in Elsevier Vigneresse, Jean-Louis ELSEVIER How do metals escape from magmas to form porphyry-type ore deposits? 2018 official journal of the Association for Research into Arterial Structure and Physiology Amsterdam [u.a.] (DE-627)ELV001651668 volume:18 year:2017 pages:49-54 extent:6 https://doi.org/10.1016/j.artres.2017.03.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.52 Geologie der Erze VZ 57.20 Exploration und Prospektion von Bodenschätzen VZ AR 18 2017 49-54 6 045F 610 |
| allfieldsGer |
10.1016/j.artres.2017.03.002 doi GBVA2017010000010.pica (DE-627)ELV020247451 (ELSEVIER)S1872-9312(16)30097-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl Vlachopoulos, Charalambos verfasserin aut Practical solutions for hypertensive patients with dyslipidemia 2017transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Elsevier Ioakeimidis, Nikolaos oth Enthalten in Elsevier Vigneresse, Jean-Louis ELSEVIER How do metals escape from magmas to form porphyry-type ore deposits? 2018 official journal of the Association for Research into Arterial Structure and Physiology Amsterdam [u.a.] (DE-627)ELV001651668 volume:18 year:2017 pages:49-54 extent:6 https://doi.org/10.1016/j.artres.2017.03.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.52 Geologie der Erze VZ 57.20 Exploration und Prospektion von Bodenschätzen VZ AR 18 2017 49-54 6 045F 610 |
| allfieldsSound |
10.1016/j.artres.2017.03.002 doi GBVA2017010000010.pica (DE-627)ELV020247451 (ELSEVIER)S1872-9312(16)30097-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl Vlachopoulos, Charalambos verfasserin aut Practical solutions for hypertensive patients with dyslipidemia 2017transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Elsevier Ioakeimidis, Nikolaos oth Enthalten in Elsevier Vigneresse, Jean-Louis ELSEVIER How do metals escape from magmas to form porphyry-type ore deposits? 2018 official journal of the Association for Research into Arterial Structure and Physiology Amsterdam [u.a.] (DE-627)ELV001651668 volume:18 year:2017 pages:49-54 extent:6 https://doi.org/10.1016/j.artres.2017.03.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.52 Geologie der Erze VZ 57.20 Exploration und Prospektion von Bodenschätzen VZ AR 18 2017 49-54 6 045F 610 |
| language |
English |
| source |
Enthalten in How do metals escape from magmas to form porphyry-type ore deposits? Amsterdam [u.a.] volume:18 year:2017 pages:49-54 extent:6 |
| sourceStr |
Enthalten in How do metals escape from magmas to form porphyry-type ore deposits? Amsterdam [u.a.] volume:18 year:2017 pages:49-54 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Geologie der Erze Exploration und Prospektion von Bodenschätzen |
| institution |
findex.gbv.de |
| topic_facet |
Hypertension Aortic stiffness Dyslipidemia Amlodipine Central pressures ACE inhibitors |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
How do metals escape from magmas to form porphyry-type ore deposits? |
| authorswithroles_txt_mv |
Vlachopoulos, Charalambos @@aut@@ Ioakeimidis, Nikolaos @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV001651668 |
| dewey-sort |
3610 |
| id |
ELV020247451 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV020247451</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625131502.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.artres.2017.03.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017010000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV020247451</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1872-9312(16)30097-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">57.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vlachopoulos, Charalambos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Practical solutions for hypertensive patients with dyslipidemia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypertension</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Aortic stiffness</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dyslipidemia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Amlodipine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Central pressures</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ACE inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ioakeimidis, Nikolaos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vigneresse, Jean-Louis ELSEVIER</subfield><subfield code="t">How do metals escape from magmas to form porphyry-type ore deposits?</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the Association for Research into Arterial Structure and Physiology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001651668</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:49-54</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.artres.2017.03.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.52</subfield><subfield code="j">Geologie der Erze</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">57.20</subfield><subfield code="j">Exploration und Prospektion von Bodenschätzen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2017</subfield><subfield code="h">49-54</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Vlachopoulos, Charalambos |
| spellingShingle |
Vlachopoulos, Charalambos ddc 610 ddc 550 bkl 38.52 bkl 57.20 Elsevier Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Practical solutions for hypertensive patients with dyslipidemia |
| authorStr |
Vlachopoulos, Charalambos |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001651668 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 550 - Earth sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl Practical solutions for hypertensive patients with dyslipidemia Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors Elsevier |
| topic |
ddc 610 ddc 550 bkl 38.52 bkl 57.20 Elsevier Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors |
| topic_unstemmed |
ddc 610 ddc 550 bkl 38.52 bkl 57.20 Elsevier Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors |
| topic_browse |
ddc 610 ddc 550 bkl 38.52 bkl 57.20 Elsevier Hypertension Elsevier Aortic stiffness Elsevier Dyslipidemia Elsevier Amlodipine Elsevier Central pressures Elsevier ACE inhibitors |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n i ni |
| hierarchy_parent_title |
How do metals escape from magmas to form porphyry-type ore deposits? |
| hierarchy_parent_id |
ELV001651668 |
| dewey-tens |
610 - Medicine & health 550 - Earth sciences & geology |
| hierarchy_top_title |
How do metals escape from magmas to form porphyry-type ore deposits? |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001651668 |
| title |
Practical solutions for hypertensive patients with dyslipidemia |
| ctrlnum |
(DE-627)ELV020247451 (ELSEVIER)S1872-9312(16)30097-7 |
| title_full |
Practical solutions for hypertensive patients with dyslipidemia |
| author_sort |
Vlachopoulos, Charalambos |
| journal |
How do metals escape from magmas to form porphyry-type ore deposits? |
| journalStr |
How do metals escape from magmas to form porphyry-type ore deposits? |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
49 |
| author_browse |
Vlachopoulos, Charalambos |
| container_volume |
18 |
| physical |
6 |
| class |
610 610 DE-600 550 VZ 38.52 bkl 57.20 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Vlachopoulos, Charalambos |
| doi_str_mv |
10.1016/j.artres.2017.03.002 |
| dewey-full |
610 550 |
| title_sort |
practical solutions for hypertensive patients with dyslipidemia |
| title_auth |
Practical solutions for hypertensive patients with dyslipidemia |
| abstract |
Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. |
| abstractGer |
Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. |
| abstract_unstemmed |
Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO |
| title_short |
Practical solutions for hypertensive patients with dyslipidemia |
| url |
https://doi.org/10.1016/j.artres.2017.03.002 |
| remote_bool |
true |
| author2 |
Ioakeimidis, Nikolaos |
| author2Str |
Ioakeimidis, Nikolaos |
| ppnlink |
ELV001651668 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.artres.2017.03.002 |
| up_date |
2024-07-06T17:05:52.208Z |
| _version_ |
1803850143195201536 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV020247451</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625131502.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.artres.2017.03.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017010000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV020247451</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1872-9312(16)30097-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">57.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vlachopoulos, Charalambos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Practical solutions for hypertensive patients with dyslipidemia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Arterial hypertension and dyslipidemia often coexist and constitute major risk factors of ischemic heart disease. Aggressive treatment of both comorbidities is of paramount importance to decrease global risk. Low adherence is a determinant of poor risk factor control and increases adverse cardiovascular outcomes. Regarding treatment of hypertension, combination therapy is superior in achieving target BP values compared to up-titrating monotherapy and it is recommended in hypertension guidelines. The combined use of drugs in a single pill formulation increases adherence and reduces cardiovascular risk. Our review of the literature indicates that triple therapy with an angiotensin converting enzyme inhibitor, a calcium channel blocker and a statin is associated with a significant reduction in major cardiovascular events. This is attributed to synergy at the vascular, and is translated into efficacy at the clinical level.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypertension</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Aortic stiffness</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dyslipidemia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Amlodipine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Central pressures</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ACE inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ioakeimidis, Nikolaos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vigneresse, Jean-Louis ELSEVIER</subfield><subfield code="t">How do metals escape from magmas to form porphyry-type ore deposits?</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the Association for Research into Arterial Structure and Physiology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001651668</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:49-54</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.artres.2017.03.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.52</subfield><subfield code="j">Geologie der Erze</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">57.20</subfield><subfield code="j">Exploration und Prospektion von Bodenschätzen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2017</subfield><subfield code="h">49-54</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.402298 |